TEST NOW,
ASSESSING YOUR RISK IS SIMPLE

HOW TO TEST

Genetic testing is easy and affordable. You can order a test from Color Health through Yodeah, and mail in a saliva test from home. Color Health, a clinical-grade genomics lab, has partnered with the American Cancer Society to promote cancer screenings and is a HIPAA-covered entity that follows all HIPAA privacy and security risks for safeguarding protected health information (PHI).

We encourage you to read the Know Before You Test section on this page.

Click here for the list of genes included in the Color Health test.

ENTER OUR CODE KNOW30 AT CHECKOUT AND THE COST WILL CHANGE FROM $299 TO YODEAH'S DISCOUNTED RATE OF $149.

You can also test through your doctor's office or a genetic counselor.

WHAT TO KNOW BEFORE YOU TEST

Play Video

Remember, most cancers are not related to a known specific hereditary cancer mutation, so you should never neglect age-appropriate screening, taking into account your individualized risk, including family and personal history.

This information is for guidance only. It is not meant to give specific medical advice. Always consult your healthcare provider for appropriate directions.

Yodeah does not provide medical services, make medical referrals or endorse or promote any specific medication, treatment, product or service. Links provided on this website to order test kits are provided solely as a convenience to this website’s visitors. Yodeah is not responsible for the processing of test kits or the provision of test results for any testing service. Yodeah makes no representations regarding the accuracy or efficacy of any testing service.

Yodeah’s mission is to educate and facilitate cost-effective testing for hereditary cancer genetic mutations in the Jewish community, a process known as population-based testing. Yodeah does not give medical advice. We recommend you contact your healthcare professional for any questions about cancer or genetic testing. Genetic testing is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up.

THE MOST RELEVANT GENES FOR COMMON HEREDITARY CANCERS

* CDK4: analysis is limited to chr12:g.58145429-58145431 (codon 24). EPCAM: analysis is limited to deletions that minimally encompass the 3′ end of the gene including exons 8 and/or 9. GREM1: analysis is limited to duplications that overlap the upstream regulatory region. MITF: analysis is limited to chr3:g.70014091 (including c.952G>A). MUTYH: single heterozygous pathogenic variants, likely pathogenic variants, and variants of uncertain significance are not reported. PMS2: variants of uncertain significance are not reported for exons 12-15. Analysis excludes three variants commonly observed in the pseudogene PMS2CL: c.2182_2184delinsG, c.2243_2246delAGAA and deletion of exons 13-14 (chr7:g.6015768_6018727del). POLD1: analysis is limited to chr19:g.50909713 (including c.1433G>A). POLE: analysis is limited to chr12:g.133250250 (including c.1270C>G).